KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Net Cash Flow (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,020.57%
Dec 31, 2025 -122.30%
Sep 30, 2025 281.20%
Jun 30, 2025 75.28%
Mar 31, 2025 -206.79%
Dec 31, 2024 1,121.38%
Sep 30, 2024 28.75%
Jun 30, 2024 67.07%
Mar 31, 2024 94.81%
Dec 31, 2023 -4,926.98%
Sep 30, 2023 -81.66%
Jun 30, 2023 -88.77%
Mar 31, 2023 1,377.68%
Dec 31, 2022 -143.57%
Sep 30, 2022 424.45%
Jun 30, 2022 9.31%
Mar 31, 2022 63.29%
Dec 31, 2021 -174.55%
Sep 30, 2021 930.69%
Jun 30, 2021 436.36%
Mar 31, 2021 94.54%
Dec 31, 2020 -4,763.79%
Sep 30, 2020 -103.98%
Jun 30, 2020 -11.64%
Mar 31, 2020 130.68%
Dec 31, 2019 -191.31%
Sep 30, 2019 421.33%
Jun 30, 2019 -543.83%
Mar 31, 2019 108.24%
Dec 31, 2018 -374.58%
Sep 30, 2018 367.95%
Jun 30, 2018 -93.44%
Mar 31, 2018 642.63%
Dec 31, 2017 115.63%
Sep 30, 2017 150.89%
Jun 30, 2017 -723.08%
Mar 31, 2017 147.95%
Dec 31, 2016 -128.54%
Sep 30, 2016 421.43%
Jun 30, 2016 78.69%
Mar 31, 2016 -235.95%
Dec 31, 2015 261.34%
Sep 30, 2015 -161.12%
Jun 30, 2015 207.38%
Mar 31, 2015 -1,705.56%
Dec 31, 2014 108.00%
Sep 30, 2014 -201.50%
Jun 30, 2014 663.56%
Mar 31, 2014 97.36%
Dec 31, 2013 -280.85%
Sep 30, 2013 -24.45%
Jun 30, 2013 550.62%
Mar 31, 2013 71.67%
Dec 31, 2012 -9,769.23%
Sep 30, 2012 -101.58%
Jun 30, 2012 159.95%
Mar 31, 2012 -189.66%
Dec 31, 2011 244.99%
Sep 30, 2011 -144.53%
Jun 30, 2011 334.14%
Mar 31, 2011 -701.49%
Dec 31, 2010 -72.88%
Sep 30, 2010 323.65%
Jun 30, 2010 10.36%
Mar 31, 2010 10.82%
Dec 31, 2009 -213.79%
Sep 30, 2009 218.85%
Jun 30, 2009 -80.96%